文献速递生殖医学

肯尼亚备孕女性中生殖支原体感染与生育力关联的前瞻性孕前队列研究

A prospective preconception cohort study of the association between Mycoplasma genitalium and fecundability in Kenyan women trying to conceive.
PubMed 文献 · Hum Reprod · 2023-01-01

在肯尼亚407名尝试受孕≤6个月的女性中开展前瞻性孕前队列,检测阴道液生殖支原体并行每月妊娠测试。生殖支原体感染与生育力降低27%相关但置信区间宽(aFR 0.73,95%CI 0.44,1.23),且该关联可能取决于合并细菌性阴道病(BV)。

要点

  • 孕前生殖支原体感染与生育力降低27%相关,但置信区间宽(aFR 0.73,95%CI 0.44,1.23)。
  • 同时感染生殖支原体和BV者生育力降低51%(aFR 0.49,95%CI 0.22,1.09),单独生殖支原体感染无关联(aFR 0.98,95%CI 0.54,1.76)。
  • 仅BV者生育力降低幅度较小(aFR 0.80,95%CI 0.60,1.07),提示生殖支原体与BV可能存在协同效应。

核心结论

  • 孕前生殖支原体感染与生育力降低27%相关但置信区间宽,且该关联可能取决于合并BV。

研究设计与样本

  • 前瞻性孕前队列研究,纳入肯尼亚407名尝试受孕≤6个月的女性,采集阴道液标本并行每月妊娠测试。
  • 使用核酸扩增试验检测储存样本中的生殖支原体,采用离散时间比例概率模型估计生育力比。

主要发现

  • 407名参与者共经历1220个月经周期和213次妊娠,入组时生殖支原体感染率为7.7%。
  • 调整年龄、近4周无保护性交频率和研究现场后,生殖支原体与生育力降低27%相关(aFR 0.73,95%CI 0.44,1.23)。
  • 与无生殖支原体且无BV的周期相比,同时有生殖支原体和BV者生育力降低51%(aFR 0.49,95%CI 0.22,1.09)。
  • 单独生殖支原体感染与生育力无关联(aFR 0.98,95%CI 0.54,1.76),仅BV者生育力降低幅度较小(aFR 0.80,95%CI 0.60,1.07)。

局限性

  • 生殖支原体感染率相对较低且置信区间宽,结果应谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is Mycoplasma genitalium-infection associated with reduced fecundability? SUMMARY ANSWER: Preconception M. genitalium-infection was associated with 27% lower fecundability though confidence intervals were wide, and the association between M. genitalium and fecundability may be dependent on concurrent bacterial vaginosis (BV). WHAT IS KNOWN ALREADY: M. genitalium has been associated with cervicitis, pelvic inflammatory disease, infertility, and preterm birth, but the extent to which M. genitalium is causally related to adverse reproductive sequelae in women is debated. STUDY DESIGN, SIZE, DURATION: Kenyan women enrolled in a prospective preconception cohort provided vaginal fluid specimens and underwent monthly pregnancy testing. Stored samples from 407 women who had been trying to conceive for ≤6 months were tested for M. genitalium using a nucleic acid amplification test. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data on first day of last menstrual period, sexual behavior, pregnancy status, and vaginal specimens were collected at monthly preconception visits. The association between M. genitalium detected at the visit prior to each pregnancy test and fecundability was estimated using discrete time proportional probabilities models. Secondary analyses explored the influence of concurrent BV on the association between M. genitalium and fecundability. MAIN RESULTS AND THE ROLE OF CHANCE: The 407 participants experienced 1220 menstrual cycles and 213 pregnancies. The prevalence of M. genitalium at enrollment was 7.7%. After adjustment for age, frequency of condomless sex in the last 4 weeks, and study site, M. genitalium was associated with a 27% lower fecundability, but confidence intervals were wide (adjusted fecundability ratio (aFR) 0.73, 95% CI 0.44, 1.23). In secondary analyses, when compared to cycles without M. genitalium or BV at the visit prior, women with both M. genitalium and BV at the visit prior had a 51% lower fecundability (aFR = 0.49, 95% CI 0.22, 1.09) whereas there was no association of M. genitalium alone (aFR = 0.98 (95% CI 0.54, 1.76)), and a smaller reduction in fecundability for women with BV only (aFR = 0.80 (95% CI 0.60, 1.07)). LIMITATIONS, REASONS FOR CAUTION: Results should be interpreted cautiously given the relatively low prevalence of M. genitalium and wide confidence intervals. WIDER IMPLICATIONS OF THE FINDINGS: In this cohort of Kenyan women trying to conceive, the association between M. genitalium and fecundability was influenced by concurrent BV status, suggesting there may be a synergistic effect of M. genitalium and BV on fecundability. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a National Institutes of Health grant (NICHD R01 HD087346-RSM). R.S.M. received additional support for mentoring (NICHD K24 HD88229). E.M.L. was supported by pre- and post-doctoral fellowships (NIAID T32 AI07140, NICHD F32 HD100202). Data collection and management were completed using REDCap electronic data capture tools hosted at the University of Washington's Institute of Translational Health Science supported by grants from NCATS/NIH (UL1 TR002319). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. R.S.M. receives research funding, paid to the University of Washington, from Hologic Corporation and consulting fees from Lupin Pharmaceuticals. L.E.M. receives research funding and material for research studies, paid to the University of Washington, from Hologic Corporation and Nabriva Therapeutics, travel support from Hologic, and consulting fees from Health Advances. E.M.L.'s contributions to this study primarily occurred while affiliated with the University of Washington; at the time of submission, E.M.L. was an employee of and holds stock or stock grants for AbbVie, Inc. The other authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lokken EM, Kabare E, Oyaro B, et al. A prospective preconception cohort study of the association between Mycoplasma genitalium and fecundability in Kenyan women trying to conceive. Hum Reprod. 2023. PMID: 37634090. doi:10.1093/humrep/dead172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。